The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Enterococci are common gut commensals, gaining significance in research post-1980s with the discovery of vancomycin-resistant enterococci (VRE).
• Enterococcus faecium is recognized by the WHO as a critical pathogen requiring urgent development of new antibiotics.
• The increasing prevalence of VRE infections poses a significant public health challenge due to limited effective treatment options.

Purpose of the Study:

• To provide a comprehensive overview of vancomycin-resistant enterococci (VRE).
• To review the current landscape of VRE, including mortality rates, antibiotic resistance patterns, and virulence factors.
• To explore limitations of existing VRE therapies and highlight promising novel treatment strategies.

Main Methods:

• Literature review of VRE epidemiology, clinical impact, and therapeutic interventions.
• Analysis of antibiotic resistance profiles and virulence mechanisms associated with VRE.
• Evaluation of preclinical and clinical studies on emerging VRE treatments, including bacteriocins and animal models.

Main Results:

• VRE infections are associated with significant mortality and morbidity.
• Diverse antibiotic resistance mechanisms contribute to the therapeutic challenges posed by VRE.
• Animal models provide insights into VRE pathogenesis and treatment efficacy.

Conclusions:

• The rise of VRE necessitates urgent development of new antimicrobial agents.
• Bacteriocins and other innovative approaches show potential for combating VRE infections.
• Continued research into VRE virulence and resistance is crucial for effective clinical management.